Drugs / premixed insulin NPH 30/70
last change Aug 2003 re-read 2 minutes ago

premixed insulin NPH 30/70

Protein / enzyme biologic

Developed for
type 2 diabetes mellitus

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00783744 Comparator Dec 2001 → Aug 2003 type 2 diabetes mellitus Sanofi Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as premixed insulin NPH 30/70 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00783744
Modality Protein / enzyme biologic “premixed insulin NPH 30/70” NCT00783744